FDA on Monday (May 2) announced several organizational changes within its device center that include standing up two new health technology offices focused on providing sponsors with specific information and guidance related to in vitro diagnostics and radiological products. The agency also created a new regulatory systems division intended to support the device center’s internal digital work and processes and help with work in the health technology offices. In total, the agency has created two new offices and two new...